Journal article · 2026 · Open access

Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard

John D. Schuetz, Richard B. Kim

Clinical Pharmacology & Therapeutics · Published 8 November 2026 · DOI 10.1002/cpt.70557

Open PDFView at the publisherCite this paper

In brief

“Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard” is a 2026 journal article by John D. Schuetz and Richard B. Kim, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 16 November 2026. It is open access: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
0
References
10
Authors
2

Abstract

Genomic findings can sharpen therapeutic decisions, but they can also provide false reassurance. In precision oncology, labels such as benign, nonactionable, or explanatory may be mistaken for evidence that symptoms or abnormal findings require no further evaluation. This Perspective argues that genotype-phenotype discordance should be treated as a safety signal. Simple report language, tumor-board checks, and artificial intelligence guardrails can preserve the value of genomics without allowing a molecular explanation to become diagnostic closure.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Schuetz, J. D., & Kim, R. B. (2026). Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70557

MLA 9

Schuetz, John D., and Richard B. Kim. “Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70557.

Chicago

Schuetz, John D. and Richard B. Kim. 2026. “Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70557.

Harvard

Schuetz, J. D. and Kim, R. B. (2026) ‘Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70557.

IEEE

J. D. Schuetz and R. B. Kim, “Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70557.

BibTeX

@article{schuetz2026genomic,
  title     = {{Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard}},
  author    = {Schuetz, John D. and Kim, Richard B.},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2026},
  doi       = {10.1002/cpt.70557},
  url       = {https://doi.org/10.1002/cpt.70557}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases

  • precision oncology
  • genotype-phenotype discordance
  • safety signals

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Schuetz, J. D., & Kim, R. B. (2026). Genomic Reassurance and Diagnostic Closure in Precision Oncology: A Preventable Hazard. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70557

How many times has this paper been cited?

0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

John D. Schuetz, Richard B. Kim.

What is the DOI of this paper?

10.1002/cpt.70557, permanently at https://doi.org/10.1002/cpt.70557. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.